CVS 2012 Annual Report Download - page 55

Download and view the complete annual report

Please find page 55 of the 2012 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 92

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92

CVS CAREMARK 2012 ANNUAL REPORT
53
Consolidated Balance Sheets
December 31,
In millions, except per share amounts
2012 2011
Assets:
Cash and cash equivalents $ 1,375 $ 1,413
Short-term investments
5 5
Accounts receivable, net 6,473 6,047
Inventories
10,759 10,046
Deferred income taxes 663 503
Other current assets 577 580
Total current assets 19,852 18,594
Property and equipment, net 8,632 8,467
Goodwill
26,395 26,458
Intangible assets, net 9,753 9,869
Other assets
1,280 1,155
Total assets
$ 65,912 $ 64,543
Liabilities:
Accounts payable
$ 5,070 $ 4,370
Claims and discounts payable 3,974 3,487
Accrued expenses
4,051 3,293
Short-term debt
690 750
Current portion of long-term debt 5 56
Total current liabilities 13,790 11,956
Long-term debt
9,133 9,208
Deferred income taxes 3,784 3,853
Other long-term liabilities 1,501 1,445
Commitments and contingencies (Note 13)
Redeemable noncontrolling interest — 30
Shareholders’ equity:
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding — —
Common stock, par value $0.01: 3,200 shares authorized; 1,667 shares issued and 1,231 shares
outstanding at December 31, 2012 and 1,640 shares issued and 1,298 shares outstanding
at December 31, 2011 17 16
Treasury stock, at cost: 435 shares at December 31, 2012 and 340 shares at December 31, 2011 (16,270) (11,953)
Shares held in trust: 1 share at December 31, 2012 and 2 shares at December 31, 2011 (31) (56)
Capital surplus
29,120 28,126
Retained earnings
25,049 22,090
Accumulated other comprehensive loss (181) (172)
Total shareholders’ equity 37,704 38,051
Total liabilities and shareholders’ equity $ 65,912 $ 64,543
See accompanying notes to consolidated financial statements.